Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Bupivacaine for Pain Management in Clavicle Fracture ORIF
NCT03020563Phase 4Withdrawn
- Sponsor
- University of Minnesota
- Start
- Aug 2017
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of liposomal bupivacaine in Clavicle fracture, sponsored by University of Minnesota. Planned start Aug 2017; status: withdrawn.
02
Drugs
liposomal bupivacaine
03
Conditions
Clavicle fracture
Beyond the preview
Go deeper on NCT03020563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03020563.